Me3Al-mediated domino nucleophilic addition/intramolecular cyclisation of 2-(2-oxo-2-phenylethyl)benzonitriles with amines; a convenient approach for the synthesis of substituted 1-aminoisoquinolines

  1. Krishna M. S. Adusumalli1,2,
  2. Lakshmi N. S. Konidena1,
  3. Hima B. Gandham2,
  4. Krishnaiah Kumari1,
  5. Krishna R. Valluru1,
  6. Satya K. R. Nidasanametla1ORCID Logo,
  7. Venkateswara R. Battula2 and
  8. Hari K. Namballa1,3ORCID Logo

1GVK Biosciences Private Limited, Medicinal Chemistry Laboratory, Hyderabad 500076, India
2Department of Engineering Chemistry, Andhra University College of Engineering (A), Andhra University, Visakhapatnam 530003, India
3Department of Chemistry, Hunter College, City University of New York, 695 Park Avenue, NY 10065, USA

  1. Corresponding author email

Associate Editor: B. Stoltz
Beilstein J. Org. Chem. 2021, 17, 2765–2772. https://doi.org/10.3762/bjoc.17.186
Received 22 Mar 2021, Accepted 25 Oct 2021, Published 16 Nov 2021

A non-peer-reviewed version of this article has been posted as a preprint https://doi.org/10.3762/bxiv.2021.26.v1

Abstract

A simple and efficient protocol for the construction of 1-aminoisoquinolines was achieved by treating 2-(2-oxo-2-phenylethyl)benzonitriles with amines in the presence of Me3Al. The reaction proceeds via a domino nucleophilic addition with subsequent intramolecular cyclisation. This method provides a wide variety of substituted 1-aminoisoquinolines with good functional group tolerance. Furthermore, the synthetic utility of this protocol was demonstrated in the successful synthesis of the antitumor agent CWJ-a-5 in gram scale.

Keywords: 1-aminoisoquinolines; CWJ-a-5; intramolecular cyclisation; 2-(2-oxo-2-phenylethyl)benzonitriles; nucleophilic addition

Introduction

Heterocyclic compounds have always been recognized as the frameworks of interest in organic and medicinal fields. Particularly, aza-heteroarenes have attracted burgeoning interest in the research community owing to their structural and biological significance [1-4]. The isoquinoline template represents a huge family of aza-heterocycles with unparalleled structural diversity, and is considered to be associated with a huge range of applications in medicinal and materials sciences [5-12]. 1-Amino substituted isoquinoline derivatives are extensively studied owing to their therapeutic applications in medicinal chemistry such as antimalarial, anti-Parkinson and antitumor activity (Figure 1) [13-17]. They also display remarkable enzymatic inhibitory activities on topoisomerase I, [18] mutant B-Raf [19] and exhibit antagonistic activities towards adenosine A3 [20] and PDE4B [21] receptors. They are useful in the synthesis of phosphorescent materials [22-24], fluorosensors [25]. and also found as chiral ligands in a variety of transition metal catalysts [26-30].

[1860-5397-17-186-1]

Figure 1: Biologically active 1-aminoisoquinolines.

Given the pharmacological promiscuity of this scaffold, extensive efforts from different groups led to the development of several approaches for the efficient construction of these heterocyclic frameworks (Scheme 1). Traditional preparations for 1-aminoisoquinolines include nucleophilic substitution of 1-haloisoquinolines with amines either employing a base [31-35] or a transition metal catalyst [36-40]. However, pre-functionalization of isoquinolines to the corresponding halogenated isoquinolines is the main limitation associated with these protocols as they require noxious halogenated acids for their starting materials preparation. Alternative strategies include, amination of isoquinoline N-oxides [41,42], condensation of lithiated o‐tolualdehyde tert‐butylimines with nitriles [43], electrophilic cyclization of 2-alkynylbenzamides [44,45] or 2-alkynylbenzaldoximes [46-54], oxidative C–H functionalizations (coupling) on aryl and heteroaryl amidines with alkynes catalyzed by either rhodium or ruthenium [55-57], or a metal-catalyzed aminative cyclization of 2-alkynylbenzonitriles with secondary amines [58]. Despite the advantages associated with the aforementioned protocols such as the functional group tolerance and huge substrate scope, they are associated with few limitations including: utilization of metals, transition metals, and difficulties in accessing the starting materials, which provoke the attention of the synthetic community for the development of simple and efficient methodologies towards the construction of these heterocyclic frameworks.

[1860-5397-17-186-i1]

Scheme 1: Comparison of our work with the previous approaches for the synthesis of 1-aminoisoquinolines.

On the other hand, organonitrile, the polar unsaturated carbon−nitrogen multiple bond, recognized as one of the most versatile chemotypes in both the laboratory and industry because of their vital role displayed in various transformations [1-4]. They capture a major area in the synthesis of a wide array of heterocyclic compounds by creating C–C, C–N, C–O and C–S bonds due to their ability to act as electrophiles. The cyano group is considered as a versatile functional group in various organic syntheses because of its participation in various electrophilic, necleophilic and bipolar cycloaddition reactions and also serves as a precursor for the generation of important functional groups like amines, aldehydes, ketones and carboxylic acids. Even though the nitrile functional group is prevalent in the transformation into different functional groups, the synthetic approaches that incorporate the nitrogen atom of the cyano group into heterocyclic products is still challenging for the synthetic community. In an effort to develop a synthetic strategy for 1-aminoisoquinolines with increased selectivity and step economy by minimizing the generation of byproducts, we hypothesized that if suitably tailored benzonitriles 3 were cyclized in an intramolecular fashion by installing nuclophilic nitrogen onto the nitrile functionality would generate 1-aminoisoquinolines. Herein we describe our efforts on a Me3Al-mediated nucleophilic addition followed by an intramolecular cyclisation of 2-(2-oxo-2-phenylethyl)benzonitriles with amines to deliver 1-aminoisoquinolines and its successful application in the synthesis of antitumor agent CWJ-a-5.

Results and Discussion

Initially we targeted the synthesis of 2-(2-oxo-2-phenylethyl)benzonitrile (3a) by reacting 2-methylbenzonitrile with the appropriate ester of benzoic acid in the presence of a base. After having the starting material in hand, we commenced our investigations for the synthesis of 1-aminoisoquinolines by treating 2-(2-oxo-2-phenylethyl)benzonitrile (3a) with aniline (4a) in the presence of different Lewis acids under varying reaction parameters. Formation of no desired product was observed when the reaction was carried out in BF3·OEt2 in toluene under reflux conditions (Table 1, entry 1). To our delight, the expected product 5a was formed in 18% yield in the presence of TiCl4 (Table 1, entry 2). AlCl3 was also found to be inefficient for this transformation under similar reaction conditions yielding the desired product only in 16% yield (Table 1, entry 3). Interestingly, a substantial improvement in the yield of the reaction was observed by switching to Me3Al in toluene at 110 °C, delivering 85% of the desired product in 8 h (Table 1, entry 4). Moreover, TMS-OTf was also found to be not much effective as MeAl3 leading to generation of the desired product in comparably lesser yields than Me3Al (Table 1, entry 5). After identifying the suitable Lewis acid for this transformation, we next moved to optimize other reaction parameters such as solvent and temperature. From the list of solvents tested, it is clear that toluene was the solvent of choice, better than DCM, DCE, THF and dioxane (Table 1, entries 5–9). The temperature of the reaction also has notifiable impact on the yields, where increasing the reaction temperature beyond 110 °C or decreasing the reflux temperature led to a slight decrease in the yields of the product (Table 1, entries 10 and 11). No desired product was observed when the reaction was performed at room temperature (Table 1, entry 12).

Table 1: Optimization of the reaction conditions for the synthesis of 1-aminoisoquinolines.a

[Graphic 1]
Entry Lewis acid (equiv) Solvent Temperature (°C) Time (h) Yield (%)b
1 BF3·OEt2 (2) toluene 110 8
2 TiCl4 (2) toluene 110 8 18
3 AlCl3 (2) toluene 110 8 16
4 Me3Al (2) toluene 110 8 85
5 TMS-OTf (2) toluene 110 8 45
6 Me3Al (2) DCM 40 8 34
7 Me3Al (2) dioxane 100 8 50
8 Me3Al (2) DCE 80 8 48
9 Me3Al (2) THF 60 8 27
10 Me3Al (2) toluene 90 8 63
11 Me3Al (2) toluene 130 8 82
12 Me3Al (2) toluene rt 12

aReaction conditions: 3a (1 equiv), 4a (1.5 equiv) in the presence of Lewis acid (2 equiv). bIsolated yield.

With the optimal reaction conditions in hand, we next explored the substrate scope of this protocol. Initially, 2-(2-oxo-2-phenylethyl)benzonitrile (3a) was treated with various anilines under the optimized reaction conditions (Scheme 2). The yields of the reactions were not influenced significantly by the electronic effects of the substituents. However, the steric effects of the substituents have influenced the yields of the reaction substantially. Comparably better yields were observed with electron donating substituents than the electron withdrawing halo groups on the aniline ring (Scheme 2, 5bm). Importantly, the steric effects on the aniline ring have huge impact on the reaction efficiency and efficacy, where para- and meta-substituents have minimal impact on the yields of the reaction delivering the corresponding products in comparable yields (Scheme 2). While least yields were observed with ortho-substituted anilines (Scheme 2, 5h and 5k), which can be rationalized by the steric hindrance created by the ortho-substituents. It is also worth mentioning that secondary anilines also reacted with 2-(2-oxo-2-phenylethyl)benzonitrile (3a) and delivered the corresponding product 5m, albeit in lesser yields.

[1860-5397-17-186-i2]

Scheme 2: Substrate scope of anilines for the synthesis of 1-aminoisoquinolines (5am). Reaction conditions: 3 (1 equiv), 4 (1.5 equiv), Me3Al (2 equiv) in toluene at 110 °C for 8 h. Isolated yields are shown.

Later, the substrate scope of 2-(2-oxo-2-phenylethyl)benzonitriles was also examined. Scheme 3 summarizes the scope of 2-(2-oxo-2-phenylethyl)benzonitriles (3be) towards the domino nucleophilic addition followed by an intramolecular cyclisation of 2-(2-oxo-2-phenylethyl)benzonitriles with amines under optimal reaction conditions. Accordingly, 2-(2-oxo-2-phenylethyl)benzonitriles substituted with various groups (Br, Cl and methyl) on both the benzene rings were treated with different anilines to yield respective products (5am) in good yields (Scheme 3). Examination of the effect of the substituents on the reaction revealed that the substituents on both the benzene rings of 2-(2-oxo-2-phenylethyl)benzonitriles have no significant impact on the yields of the reaction delivering the corresponding products in almost similar yields (3be, Scheme 3).

[1860-5397-17-186-i3]

Scheme 3: Substrate scope of 2-(2-oxo-2-phenylethyl)benzonitrile (3b–e) for the synthesis of 1-aminoisoquinolines (5nu). Reaction conditions: 3 (1 equiv), 4 (1.5 equiv), Me3Al (2 equiv) in toluene at 110 °C for 8 h. Isolated yields are shown.

Interestingly, different alkylamines such as methylamine, ethylamine and piperazines were also found to be compatible with the present protocol delivering the corresponding 1-aminoisoquinolines (5vx) in good yields (Scheme 4). The synthetic utility of this method was further extended towards the gram-scale synthesis of the antitumor agent CWJ-a-5. Accordingly, 2-(2-oxo-2-phenylethyl)benzonitrile (3a) was treated with 1-methylpiperazine (6) under the optimized reaction conditions for 8 h, which delivered antitumor agent CWJ-a-5 (1) in 81% yield (Scheme 4).

[1860-5397-17-186-i4]

Scheme 4: Substrate scope of aliphatic amines for the synthesis of 1-aminoisoquinolines (5vx), gram-scale synthesis of antitumor agent CWJ-a-5 (1). Reaction conditions: 3 (1 equiv), 4 (1.5 equiv), Me3Al (2 equiv) in toluene at 110 °C for 8 h. Isolated yields are shown.

The mechanism for the formation of 1-aminoisoquinolines was depicted in Scheme 5. Initially, 2-(2-oxo-2-phenylethyl)benzonitrile (3) condenses with amine/aniline in the presence of Me3Al to afford imine intermediate A. Intermediate A then underdoes an intramolecular cyclisation to afford intermediate B. This intermediate B then undergoes an N-[1,3]-shift leading to the generation of intermediate C, which subsequently abstracts a proton to yield the product 5.

[1860-5397-17-186-i5]

Scheme 5: Proposed mechanism for the synthesis of 1-aminoisoquinoline 5a.

Conclusion

In summary, an efficient Me3Al-mediated domino nucleophilic addition with a subsequent intramolecular cyclisation on 2-(2-oxo-2-phenylethyl)benzonitriles with amines was developed allowing access to widely substituted 1-aminoisoquinolines. Furthermore, the synthetic utility of this protocol was demonstrated in the successful synthesis of the antitumor agent CWJ-a-5 in gram scale. Good to higher yields and a wide substrate scope are the key advantages associated with the current protocol. Further biological investigations of the synthesized compounds are currently underway.

Supporting Information

Supporting Information File 1: Experimental and analytical data.
Format: PDF Size: 2.1 MB Download

References

  1. Kukushkin, V. Y.; Pombeiro, A. J. L. Chem. Rev. 2002, 102, 1771–1802. doi:10.1021/cr0103266
    Return to citation in text: [1] [2]
  2. Enders, D.; Shilvock, J. P. Chem. Soc. Rev. 2000, 29, 359–373. doi:10.1039/a908290e
    Return to citation in text: [1] [2]
  3. Appoport, Z. The Chemistry of the Cyano Group; Wiley-Interscience: London, 1970.
    Return to citation in text: [1] [2]
  4. Larock, R. C. Comprehensive Organic Transformations: A Guide to Functional Group Preparations; VCH: New York, NY, USA, 1989.
    Return to citation in text: [1] [2]
  5. Giri, P.; Suresh Kumar, G. Mini-Rev. Med. Chem. 2010, 10, 568–577. doi:10.2174/138955710791384009
    Return to citation in text: [1]
  6. Khan, A. Y.; Suresh Kumar, G. Biophys. Rev. 2015, 7, 407–420. doi:10.1007/s12551-015-0183-5
    Return to citation in text: [1]
  7. Dembitsky, V. M.; Gloriozova, T. A.; Poroikov, V. V. Phytomedicine 2015, 22, 183–202. doi:10.1016/j.phymed.2014.11.002
    Return to citation in text: [1]
  8. He, R.; Huang, Z.-T.; Zheng, Q.-Y.; Wang, C. Tetrahedron Lett. 2014, 55, 5705–5713. doi:10.1016/j.tetlet.2014.08.077
    Return to citation in text: [1]
  9. Jin, R.; Patureau, F. W. ChemCatChem 2015, 7, 223–225. doi:10.1002/cctc.201402704
    Return to citation in text: [1]
  10. Zhang, B.; Studer, A. Chem. Soc. Rev. 2015, 44, 3505–3521. doi:10.1039/c5cs00083a
    Return to citation in text: [1]
  11. Chrzanowska, M.; Grajewska, A.; Rozwadowska, M. D. Chem. Rev. 2016, 116, 12369–12465. doi:10.1021/acs.chemrev.6b00315
    Return to citation in text: [1]
  12. Shang, X.-F.; Yang, C.-J.; Morris‐Natschke, S. L.; Li, J.-C.; Yin, X.-D.; Liu, Y.-Q.; Guo, X.; Peng, J.-W.; Goto, M.; Zhang, J.-Y.; Lee, K.-H. Med. Res. Rev. 2020, 40, 2212–2289. doi:10.1002/med.21703
    Return to citation in text: [1]
  13. Kumar, D.; Khan, S. I.; Tekwani, B. L.; Ponnan, P.; Rawat, D. S. RSC Adv. 2014, 4, 63655–63669. doi:10.1039/c4ra09768h
    Return to citation in text: [1]
  14. Yang, S. H.; Van, H. T. M.; Le, T. N.; Khadka, D. B.; Cho, S. H.; Lee, K.-T.; Chung, H.-J.; Lee, S. K.; Ahn, C.-H.; Lee, Y. B.; Cho, W.-J. Bioorg. Med. Chem. Lett. 2010, 20, 5277–5281. doi:10.1016/j.bmcl.2010.06.132
    Return to citation in text: [1]
  15. Yang, S. H.; Van, H. T. M.; Le, T. N.; Khadka, D. B.; Cho, S. H.; Lee, K.-T.; Lee, E.-S.; Lee, Y. B.; Ahn, C.-H.; Cho, W.-J. Eur. J. Med. Chem. 2010, 45, 5493–5497. doi:10.1016/j.ejmech.2010.08.042
    Return to citation in text: [1]
  16. Ghosh, B.; Antonio, T.; Zhen, J.; Kharkar, P.; Reith, M. E. A.; Dutta, A. K. J. Med. Chem. 2010, 53, 1023–1037. doi:10.1021/jm901184n
    Return to citation in text: [1]
  17. Pierre, F.; Chua, P. C.; O’Brien, S. E.; Siddiqui-Jain, A.; Bourbon, P.; Haddach, M.; Michaux, J.; Nagasawa, J.; Schwaebe, M. K.; Stefan, E.; Vialettes, A.; Whitten, J. P.; Chen, T. K.; Darjania, L.; Stansfield, R.; Anderes, K.; Bliesath, J.; Drygin, D.; Ho, C.; Omori, M.; Proffitt, C.; Streiner, N.; Trent, K.; Rice, W. G.; Ryckman, D. M. J. Med. Chem. 2011, 54, 635–654. doi:10.1021/jm101251q
    Return to citation in text: [1]
  18. Cho, W.-J.; Min, S. Y.; Le, T. N.; Kim, T. S. Bioorg. Med. Chem. Lett. 2003, 13, 4451–4454. doi:10.1016/j.bmcl.2003.09.001
    Return to citation in text: [1]
  19. Smith, A. L.; DeMorin, F. F.; Paras, N. A.; Huang, Q.; Petkus, J. K.; Doherty, E. M.; Nixey, T.; Kim, J. L.; Whittington, D. A.; Epstein, L. F.; Lee, M. R.; Rose, M. J.; Babij, C.; Fernando, M.; Hess, K.; Le, Q.; Beltran, P.; Carnahan, J. J. Med. Chem. 2009, 52, 6189–6192. doi:10.1021/jm901081g
    Return to citation in text: [1]
  20. van Muijlwijk-Koezen, J. E.; Timmerman, H.; van der Goot, H.; Menge, W. M. P. B.; Frijtag von Drabbe Künzel, J.; de Groote, M.; IJzerman, A. P. J. Med. Chem. 2000, 43, 2227–2238. doi:10.1021/jm000002u
    Return to citation in text: [1]
  21. Govek, S. P.; Oshiro, G.; Anzola, J. V.; Beauregard, C.; Chen, J.; Coyle, A. R.; Gamache, D. A.; Hellberg, M. R.; Hsien, J. N.; Lerch, J. M.; Liao, J. C.; Malecha, J. W.; Staszewski, L. M.; Thomas, D. J.; Yanni, J. M.; Noble, S. A.; Shiau, A. K. Bioorg. Med. Chem. Lett. 2010, 20, 2928–2932. doi:10.1016/j.bmcl.2010.03.023
    Return to citation in text: [1]
  22. Su, Y.-J.; Huang, H.-L.; Li, C.-L.; Chien, C.-H.; Tao, Y.-T.; Chou, P.-T.; Datta, S.; Liu, R.-S. Adv. Mater. (Weinheim, Ger.) 2003, 15, 884–888. doi:10.1002/adma.200304630
    Return to citation in text: [1]
  23. Zhao, Q.; Liu, S.; Shi, M.; Wang, C.; Yu, M.; Li, L.; Li, F.; Yi, T.; Huang, C. Inorg. Chem. 2006, 45, 6152–6160. doi:10.1021/ic052034j
    Return to citation in text: [1]
  24. Ho, C.-L.; Wong, W.-Y.; Gao, Z.-Q.; Chen, C.-H.; Cheah, K.-W.; Yao, B.; Xie, Z.-Y.; Wang, Q.; Ma, D.-G.; Wang, L.-X.; Yu, X.-M.; Kwok, H.-S.; Lin, Z.-Y. Adv. Funct. Mater. 2008, 18, 319–331. doi:10.1002/adfm.200700665
    Return to citation in text: [1]
  25. Collado, D.; Perez-Inestrosa, E.; Suau, R.; Desvergne, J.-P.; Bouas-Laurent, H. Org. Lett. 2002, 4, 855–858. doi:10.1021/ol025568m
    Return to citation in text: [1]
  26. Alcock, N. W.; Brown, J. M.; Hulmes, D. I. Tetrahedron: Asymmetry 1993, 4, 743–756. doi:10.1016/s0957-4166(00)80183-4
    Return to citation in text: [1]
  27. Chen, C.; Li, X.; Schreiber, S. L. J. Am. Chem. Soc. 2003, 125, 10174–10175. doi:10.1021/ja036558z
    Return to citation in text: [1]
  28. Durola, F.; Sauvage, J.-P.; Wenger, O. S. Chem. Commun. 2006, 171–173. doi:10.1039/b513222c
    Return to citation in text: [1]
  29. Malkov, A. V.; Kočovský, P. Eur. J. Org. Chem. 2007, 29–36. doi:10.1002/ejoc.200600474
    Return to citation in text: [1]
  30. Takenaka, N.; Sarangthem, R. S.; Captain, B. Angew. Chem., Int. Ed. 2008, 47, 9708–9710. doi:10.1002/anie.200803338
    Return to citation in text: [1]
  31. Frohn, M.; Bürli, R. W.; Riahi, B.; Hungate, R. W. Tetrahedron Lett. 2007, 48, 487–489. doi:10.1016/j.tetlet.2006.11.035
    Return to citation in text: [1]
  32. Smits, R. A.; Lim, H. D.; Hanzer, A.; Zuiderveld, O. P.; Guaita, E.; Adami, M.; Coruzzi, G.; Leurs, R.; de Esch, I. J. P. J. Med. Chem. 2008, 51, 2457–2467. doi:10.1021/jm7014217
    Return to citation in text: [1]
  33. Miller-Moslin, K.; Peukert, S.; Jain, R. K.; McEwan, M. A.; Karki, R.; Llamas, L.; Yusuff, N.; He, F.; Li, Y.; Sun, Y.; Dai, M.; Perez, L.; Michael, W.; Sheng, T.; Lei, H.; Zhang, R.; Williams, J.; Bourret, A.; Ramamurthy, A.; Yuan, J.; Guo, R.; Matsumoto, M.; Vattay, A.; Maniara, W.; Amaral, A.; Dorsch, M.; Kelleher, J. F., III. J. Med. Chem. 2009, 52, 3954–3968. doi:10.1021/jm900309j
    Return to citation in text: [1]
  34. Asagarasu, A.; Matsui, T.; Hayashi, H.; Tamaoki, S.; Yamauchi, Y.; Sato, M. Chem. Pharm. Bull. 2009, 57, 34–42. doi:10.1248/cpb.57.34
    Return to citation in text: [1]
  35. Rouchet, J.-B. E. Y.; Schneider, C.; Fruit, C.; Hoarau, C. J. Org. Chem. 2015, 80, 5919–5927. doi:10.1021/acs.joc.5b00475
    Return to citation in text: [1]
  36. Burton, G.; Cao, P.; Li, G.; Rivero, R. Org. Lett. 2003, 5, 4373–4376. doi:10.1021/ol035655u
    Return to citation in text: [1]
  37. Shen, Q.; Shekhar, S.; Stambuli, J. P.; Hartwig, J. F. Angew. Chem., Int. Ed. 2005, 44, 1371–1375. doi:10.1002/anie.200462629
    Angew. Chem. 2005, 117, 1395–1399. doi:10.1002/ange.200462629
    Return to citation in text: [1]
  38. Xie, X.; Zhang, T. Y.; Zhang, Z. J. Org. Chem. 2006, 71, 6522–6529. doi:10.1021/jo060945k
    Return to citation in text: [1]
  39. Chen, G.; Lam, W. H.; Fok, W. S.; Lee, H. W.; Kwong, F. Y. Chem. – Asian J. 2007, 2, 306–313. doi:10.1002/asia.200600322
    Return to citation in text: [1]
  40. Shen, Q.; Ogata, T.; Hartwig, J. F. J. Am. Chem. Soc. 2008, 130, 6586–6596. doi:10.1021/ja077074w
    Return to citation in text: [1]
  41. Yin, J.; Xiang, B.; Huffman, M. A.; Raab, C. E.; Davies, I. W. J. Org. Chem. 2007, 72, 4554–4557. doi:10.1021/jo070189y
    Return to citation in text: [1]
  42. He, L.; Nie, H.; Qiu, G.; Gao, Y.; Wu, J. Org. Biomol. Chem. 2014, 12, 9045–9053. doi:10.1039/c4ob01618a
    Return to citation in text: [1]
  43. Si, C.; Myers, A. G. Angew. Chem., Int. Ed. 2011, 50, 10409–10413. doi:10.1002/anie.201104769
    Return to citation in text: [1]
  44. Tovar, J. D.; Swager, T. M. J. Org. Chem. 1999, 64, 6499–6504. doi:10.1021/jo990810x
    Return to citation in text: [1]
  45. Long, Y.; She, Z.; Liu, X.; Chen, Y. J. Org. Chem. 2013, 78, 2579–2588. doi:10.1021/jo302794z
    Return to citation in text: [1]
  46. Chen, Z.; Yu, X.; Su, M.; Yang, X.; Wu, J. Adv. Synth. Catal. 2009, 351, 2702–2708. doi:10.1002/adsc.200900442
    Return to citation in text: [1]
  47. Ye, S.; Wang, H.; Wu, J. Eur. J. Org. Chem. 2010, 6436–6439. doi:10.1002/ejoc.201001040
    Return to citation in text: [1]
  48. Ye, S.; Wang, H.; Wu, J. ACS Comb. Sci. 2011, 13, 120–125. doi:10.1021/co100026y
    Return to citation in text: [1]
  49. Zheng, D.; Chen, Z.; Liu, J.; Wu, J. Org. Biomol. Chem. 2011, 9, 4763–4765. doi:10.1039/c1ob05582h
    Return to citation in text: [1]
  50. Ye, C.; Chen, Z.; Wang, H.; Wu, J. Tetrahedron 2012, 68, 5197–5202. doi:10.1016/j.tet.2012.03.081
    Return to citation in text: [1]
  51. Li, W.; Wang, Y.; Lu, T. Tetrahedron 2012, 68, 6843–6848. doi:10.1016/j.tet.2012.06.030
    Return to citation in text: [1]
  52. Wang, T.; Li, R.; Yu, D.; Gu, C.; Xiong, F.; Chen, Z. Synthesis 2014, 46, 3213–3220. doi:10.1055/s-0034-1378654
    Return to citation in text: [1]
  53. Li, Y.; Gao, L.; Zhu, H.; Li, G.; Chen, Z. Org. Biomol. Chem. 2014, 12, 6982–6985. doi:10.1039/c4ob01301h
    Return to citation in text: [1]
  54. Song, J.; Fan, C.; Liu, G.; Qiu, G. Org. Chem. Front. 2014, 1, 1045–1049. doi:10.1039/c4qo00209a
    Return to citation in text: [1]
  55. Wei, X.; Zhao, M.; Du, Z.; Li, X. Org. Lett. 2011, 13, 4636–4639. doi:10.1021/ol2018505
    Return to citation in text: [1]
  56. Jayakumar, J.; Parthasarathy, K.; Chen, Y.-H.; Lee, T.-H.; Chuang, S.-C.; Cheng, C.-H. Angew. Chem., Int. Ed. 2014, 53, 9889–9892. doi:10.1002/anie.201405183
    Angew. Chem. 2014, 126, 10047–10050. doi:10.1002/ange.201405183
    Return to citation in text: [1]
  57. Li, J.; John, M.; Ackermann, L. Chem. – Eur. J. 2014, 20, 5403–5408. doi:10.1002/chem.201304944
    Return to citation in text: [1]
  58. Reddy, V.; Jadhav, A. S.; Anand, R. V. Eur. J. Org. Chem. 2016, 453–458. doi:10.1002/ejoc.201501390
    Return to citation in text: [1]

© 2021 Adusumalli et al.; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0). Please note that the reuse, redistribution and reproduction in particular requires that the author(s) and source are credited and that individual graphics may be subject to special legal provisions.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)

 
Back to Article List

Other Beilstein-Institut Open Science Activities

Keep Informed

RSS Feed

Subscribe to our Latest Articles RSS Feed.

Subscribe

Follow the Beilstein-Institut

LinkedIn

Twitter: @BeilsteinInst